Insulin/insulin-like growth factor I hybrid receptors overexpression is not an early defect in insulin-resistant subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 11, 2000, Pages 4219-4223

  Spampinato, D ^a   Pandini, G ^a   Iuppa, A ^a   Trischitta, V ^a   Vigneri, R ^a   Frittitta, L ^a  

^a GARIBALDI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID RECEPTOR; INSULIN RECEPTOR; RECEPTOR; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE REPORT; DIABETES MELLITUS; DIABETOGENESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; SKELETAL MUSCLE;

EID: 0034527601     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.11.6977     Document Type: Article

References (28)

1. Insulin-like growth factor-I receptor β-subunit heterogeneity
2. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers
3. Characterization of human placental IGF-I/insulin hybrid receptors by protein microsequencing and purification
4. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I but not insulin with high affinity
5. Assembly of insulin/insulin-like growth factor-I hybrid receptors in vitro
6. Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects
7. Expression of insulin/insulin-like growth factor-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia
8. Role of insulin resistance in human disease
9. Early molecular defects in human insulin resistance: Studies in healthy subjects with low insulin sensitivity
10. Monodonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action
11. Monoclonal anti-peptide antibody reacting with the insulin receptor β-subunit
12. Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor
13. Molecular antibody to receptor for insulin and Somatomedin C
14. The cysteine-rich domains of the insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras
15. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor
16. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man
17. Glucose clamp technique: A method for quantifying insulin secretion and resistance
18. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: Relationship to insulin receptor tyrosine-kinase and whole body insulin sensitivity
19. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
20. Insulin and insulin-like growth factor-I (IGF-I) receptors overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: Evidence for a second mechanism of IGF-I signaling
21. Purification of insulin-like growth factor-I receptor human placental membranes
22. Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: Quantification of individual receptor species by selective immunoprecipitation and immunoblotting
23. Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues
24. Familial clustering of insulin sensitivity
25. Metabolic and genetic characterization of prediabetic states
26. Decreased insulin binding to adipocytes and circulating monocytes from obese subjects
27. Mechanisms of insulin-induced insulin-receptor down-regulation. Decreased of receptor biosynthesis and mRNA levels
28. In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglicemic clamp studies